Who are the peers of the Accent Microcell?
Accent Microcell's peers include NGL Fine Chem, Kilitch Drugs, Sakar Healthcare, Venus Remedies, Ind-Swift Labs., Zim Laboratories, Albert David, Kerala Ayurveda, Shree Ganesh Rem, and Jenburkt Pharma. In terms of management risk, Accent Microcell has an average rating, with growth rated as good and a 1-year return of -6.66%.
Peers: The peers of Accent Microcell are NGL Fine Chem, Kilitch Drugs, Sakar Healthcare, Venus Remedies, Ind-Swift Labs., Zim Laboratories, Albert David, Kerala Ayurveda, Shree Ganesh Rem, and Jenburkt Pharma.Quality Snapshot: Excellent management risk is observed at NGL Fine Chem, Venus Remedies, Albert David, and Shree Ganesh Rem, while Average management risk is found at Accent Microcell, Sakar Healthcare, Zim Laboratories, and the rest. Below Average management risk is present at Kilitch Drugs, Ind-Swift Labs., and Kerala Ayurveda. Growth is Excellent at Kilitch Drugs, Good at Accent Microcell, Average at Venus Remedies, Sakar Healthcare, and Shree Ganesh Rem, while Below Average growth is seen at NGL Fine Chem, Ind-Swift Labs., Zim Laboratories, Albert David, and Kerala Ayurveda. Capital Structure is Excellent at NGL Fine Chem, Venus Remedies, Accent Microcell, and Shree Ganesh Rem, Good at Kilitch Drugs, Average at Sakar Healthcare and Zim Laboratories, and Below Average at Ind-Swift Labs. and Kerala Ayurveda.
Return Snapshot: The peer with the highest 1-year return is Kilitch Drugs at 37.66%, while the lowest is NGL Fine Chem at -47.10%. Accent Microcell's 1-year return is -6.66%, which is higher than NGL Fine Chem but lower than Kilitch Drugs. Additionally, Ind-Swift Labs., Kerala Ayurveda, and Albert David have negative six-month returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
